Medpace Holdings, Inc. MEDP
618.88
(1.71)
(0.28%)
as of 25 Sep
- Market cap
- $17.3B
- P/E
- 35.6×
Follow MEDP
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
30.45 | 29.57 | 35.87 | 35.07 |
+8 more quarters Free account |
P/S ratio |
5.36 | 5.10 | 6.40 | 6.13 | |
P/FCF ratio |
21.11 | 19.21 | 23.76 | 21.38 | |
P/Operating CF |
92.10 | 89.99 | 84.10 | 58.76 | |
P/B ratio |
34.39 | 22.83 | 35.29 | 49.27 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
5.24 | 4.92 | 6.27 | 6.08 | |
EV/EBITDA |
23.86 | 22.28 | 28.18 | 26.78 | |
EV/Operating CF |
19.37 | 17.82 | 22.25 | 20.17 | |
EV/FCF |
20.63 | 18.52 | 23.27 | 21.19 | |
Quick Ratio |
0.66 | 0.78 | 0.67 | 0.51 | |
Current Ratio |
0.73 | 0.85 | 0.74 | 0.57 | |
Net Debt/EBITDA |
(3.27) | (4.40) | (3.10) | (1.92) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.53 | 1.33 | 1.24 | 1.23 | |
Operating CF/Net income |
1.33 | 1.23 | 1.43 | 2.22 | |
Capex/Depreciation |
(3.56) | (0.99) | (0.64) | (1.52) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.80% | 6.78% | 6.34% | 7.29% | |
Intangible Assets out of Total Assets |
0.34 | 0.33 | 0.35 | 0.40 | |
Share Based Compensation of Revenue |
0.61% | 0.70% | 0.79% | 0.96% | |
Graham Net Nets |
(0.04) | (0.03) | (0.03) | (0.05) | |
Graham Number |
77.62 | 87.67 | 74.88 | 58.67 | |
Earnings Yield |
3.28% | 3.38% | 2.79% | 2.85% | |
Free Cash Flow Yield |
4.74% | 5.21% | 4.21% | 4.68% | |
Revenue per Share |
25.11 | 24.84 | 24.56 | 23.45 | |
Operating CF per Share |
5.75 | 5.34 | 6.68 | 8.75 | |
Capex per Share |
(0.85) | (0.24) | (0.16) | (0.38) | |
Free Cash Flow per Share |
4.90 | 5.10 | 6.52 | 8.37 | |
Cash per Share |
17.84 | 22.95 | 17.23 | 10.14 | |
Shareholders Equity per Share |
15.40 | 21.03 | 15.91 | 10.44 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
15.40 | 21.03 | 15.91 | 10.44 | |
Free Cash Flow |
138.10 | 144.97 | 188.12 | 235.50 | |
Working Capital |
(385.14) | (205.96) | (354.12) | (546.63) | |
Capital Expenditures |
(23.91) | (6.81) | (4.54) | (10.71) | |
Net Current Asset Value |
(573.03) | (392.24) | (526.78) | (722.09) | |
EV/EBIT |
24.99 | 23.39 | 29.66 | 28.29 | |
Capex to Sales |
0.03 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
17.16% | 17.53% | 19.07% | 16.84% | |
Price to Operating Income |
25.58 | 24.26 | 30.29 | 28.53 | |
| Other line items | |||||
Average Receivables |
409.86 | 346.40 | 349.26 | 342.25 | |
Average Payables |
40.40 | 47.87 | 30.34 | 26.36 | |
Average Assets |
1,814.43 | 2,013.49 | 2,038.17 | 1,918.54 | |
Average Common Equity |
303.11 | 595.96 | 642.31 | 587.54 |
Columns are period end dates